(Q42262298)

19 October 2017

title

Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068. (English)

1 reference

19 October 2017

Nannan Zhou

1

1 reference

19 October 2017

Beata Nowicka-Sans

2

1 reference

19 October 2017

Brian McAuliffe

3

1 reference

19 October 2017

Neelanjana Ray

4

1 reference

19 October 2017

Betsy Eggers

5

1 reference

19 October 2017

Hua Fang

6

1 reference

19 October 2017

Li Fan

7

1 reference

19 October 2017

Matthew Healy

8

1 reference

19 October 2017

David R Langley

9

1 reference

19 October 2017

Carey Hwang

10

1 reference

19 October 2017

Max Lataillade

11

1 reference

19 October 2017

George J Hanna

12

1 reference

19 October 2017

Mark Krystal

13

1 reference

19 October 2017

language of work or name

English

0 references

publication date

14 October 2013

1 reference

Journal of Antimicrobial Chemotherapy

19 October 2017

published in

1 reference

19 October 2017

volume

69

1 reference

19 October 2017

issue

3

1 reference

19 October 2017

page(s)

573-581

1 reference

Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

Localized changes in the gp120 envelope glycoprotein confer resistance to human immunodeficiency virus entry inhibitors BMS-806 and #155.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

Antiviral activity, pharmacokinetics, and safety of BMS-488043, a novel oral small-molecule HIV-1 attachment inhibitor, in HIV-1-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

In vitro antiviral characteristics of HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

Prediction of virological response and assessment of resistance emergence to the HIV-1 attachment inhibitor BMS-626529 during 8-day monotherapy with its prodrug BMS-663068.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

Asymmetric allylboration of acyl imines catalyzed by chiral diols

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE st

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

In vivo patterns of resistance to the HIV attachment inhibitor BMS-488043.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

Naturally occurring variability in the envelope glycoprotein of HIV-1 and development of cell entry inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT412

21 January 2018

Identifiers

DOI

10.1093/JAC/DKT412

1 reference

release_e6sxblxnerdwpoadkwqj2ut4qi

19 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e6sxblxnerdwpoadkwqj2ut4qi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference